1
Technical Note The use of HIC and IEX chromatography in the purification of plasmid DNA Summary Gene therapy, or the introduction of genes into cells to prevent or fight diseases, consists of two components: a vector, for example a viral vector or lipid nanoparticle; and a payload, a custom made nucleic acid sequence. The vector then delivers the payload to patients to achieve a therapeutic effect. The two most common nucleic acid payloads used in gene therapies are messenger RNA (mRNA) and plasmid DNA (pDNA). Plasmid DNA (pDNA) is a fundamental component for the production of the viral vectors themselves, as it is used to code for the production of the particles, and is also linearised to provide a template for the mRNA products. Plasmid DNA (pDNA) are small circular double stranded DNA molecules found in bacteria which aredistinct from genomic DNA and able to replicate separately. Recombinant DNA methods are used to splice genes into plasmids, which subsequently replicate making copies of the spliced gene..Conformations of pDNA include open-circular (oc) pDNA and supercoiled (sc) pDNA. The sc isoform is the choice in DNA vaccination and gene therapy because of stability and antigenicity considerations. It is therefore important to develop purification methods which separate scDNA from ocDNA. Purification of pDNA from bacterial cells is an important step in the process. During the purification of plasmids the bacterial cells are lysed, releasing DNA and cellular components. These cellular components are subsequently removed, and the DNA-containing lysate is further processed to separate the pDNA from the genomic DNA.
Technical note: DEAE and Hexyl PuraBead® HF
1